0 Ratings
ID

11728

Description

Ticagrelor is a new, reversible binding, anti-platelet medication. Anti-platelet medications work to prevent the formation of blood clots. Ticagrelor is being developed as a treatment for patients with acute coronary syndrome (ACS). ACS is a term that is used to describe both heart attacks in progress or the imminent threat of a heart attack. ACS is usually caused by the formation of a blood clot in an artery that partially or totally blocks the blood supply to a portion of the heart muscle. Ticagrelor will be compared with clopidogrel to determine which drug, when either is used in conjunction with aspirin, is better at reducing deaths from vascular causes, future heart attacks and/or strokes in patients with ACS. https://clinicaltrials.gov/ct2/show/NCT00391872

Link

https://clinicaltrials.gov/ct2/show/NCT00391872

Keywords

Versions (1)
  1. 7/28/15 7/28/15 -
Uploaded on

July 28, 2015

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

  • Newest
  • Oldest
  • Popular
  • Newest
    • Newest
    • Oldest
    • Popular

    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility PLATO Acute Coronary Syndrome NCT00391872

    English

    Eligibility Criteria

    1 forms  
    1. StudyEvent: ODM
      1. Eligibility Criteria
    Inclusion Criteria
    Description

    Inclusion Criteria

    Male or Female
    Description

    Male or Female

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0079399
    Age > 18
    Description

    Age > 18

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0001779
    hospitalised for chest pain
    Description

    hospitalised for chest pain

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0008031
    Potential ACS
    Description

    Potential ACS

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0948089
    Exclusion Criteria
    Description

    Exclusion Criteria

    moderate or severe liver disease
    Description

    moderate or severe liver disease

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0085605
    treated with blood clotting agents that cannot be stopped
    Description

    treated with blood clotting agents that cannot be stopped

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0280087
    already been treated with an invasive (angioplasty) procedure
    Description

    already been treated with an invasive (angioplasty) procedure

    Data type

    boolean

    Alias
    UMLS CUI-1
    C0190211
    Back to the top of the page

    Similar models

    Eligibility Criteria

    1 forms
    1. StudyEvent: ODM
      1. Eligibility Criteria
    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    Inclusion Criteria
    Gender
    Item
    Male or Female
    boolean
    C0079399 (UMLS CUI-1)
    Age
    Item
    Age > 18
    boolean
    C0001779 (UMLS CUI-1)
    Chest Pain
    Item
    hospitalised for chest pain
    boolean
    C0008031 (UMLS CUI-1)
    Acute coronary syndrome
    Item
    Potential ACS
    boolean
    C0948089 (UMLS CUI-1)
    Item Group
    Exclusion Criteria
    Liver failure
    Item
    moderate or severe liver disease
    boolean
    C0085605 (UMLS CUI-1)
    blood clotting agents
    Item
    treated with blood clotting agents that cannot be stopped
    boolean
    C0280087 (UMLS CUI-1)
    Coronary angioplasty
    Item
    already been treated with an invasive (angioplasty) procedure
    boolean
    C0190211 (UMLS CUI-1)
    Back to the top of the page 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial